leadf
logo-loader
viewAbimmune Biopharma

Abimmune Biopharma aiming to 'significantly elevate' the standard of cancer care

Abimmune Biopharma CEO Flora Fan spoke with Proactive at the Biotech Showcase 2020 in San Francisco. The privately-held, San Diego-based company is developing multi-targeting immuno-oncology protein drugs. According to the company, its lead candidate will reach Investigational New Drug enablement within one year.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

District Metals shares details from most recent field work done at their...

District Metals (CVE: DMX) CEO Garrett Ainsworth joined Steve Darling from Proactive to share their initial look at some of their fieldwork that was most recently done at their property called Tomtebo. Ainsworth also talked about some of the other predrilling work the company is doing right...

12 minutes ago

2 min read